Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models
Rebekka Wittrahm, Mari Takalo, Teemu Kuulasmaa, et al.
Neurobiology of Disease (2023) Vol. 182, pp. 106140-106140
Open Access | Times Cited: 9

Showing 9 citing articles:

Natural polyphenol: Their pathogenesis-targeting therapeutic potential in Alzheimer's disease
Chengu Niu, Miaoxian Dong, Yingcai Niu
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116359-116359
Closed Access | Times Cited: 8
The impact of rare genetic variants on Alzheimer disease
Lara De Deyn, Kristel Sleegers
Nature Reviews Neurology (2025)
Closed Access | Times Cited: 1
A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer’s Disease
Douglas Galasko, Martin R. Farlow, Brendan P. Lucey, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Evaluating pathogenicity of variants of unknown significance in APP, PSEN1, and PSEN2
Jacob Marsh, Guangming Huang, Kevin M. Bowling, et al.
Neurotherapeutics (2025), pp. e00527-e00527
Open Access
Saponin components in Polygala tenuifolia as potential candidate drugs for treating dementia
Songzhe Li, Zhitao Hou, Ting Ye, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with Early Alzheimer’s Disease
Douglas Galasko, Martin R. Farlow, Brendan P. Lucey, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Electrophysiological features of cortical 3D networks are deeply modulated by scaffold properties
Francesca Callegari, Martina Brofiga, Mariateresa Tedesco, et al.
APL Bioengineering (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 1
The Icelandic mutation (APP-A673T) is protective against amyloid pathology in vivo.
Sho Shimohama, Ryo Fujioka, Naomi Mihira, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 47, pp. e0223242024-e0223242024
Closed Access
Haploinsufficiency and Alzheimer’s Disease: The Possible Pathogenic and Protective Genetic Factors
Eva Bagyinszky, Seong Soo A. An
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11959-11959
Open Access
Page 1

Scroll to top